Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall
Pfizer maintained its 2025 guidance but noted it does not include any impact of tariffs or trade policy, "which we are unable to predict at this time."
You are not logged in so some information on this page has been withheld. To see more, please log in.